Showing results (751-760 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|June 29, 2019
Meta-analysis of Dropout Rates in Placebo-Controlled Randomized Clinical Trials of Atypical Antipsychotics Assessed by PANSSAkiko Matsusaki, Masayuki Kaneko, Mamoru NarukawaClinical Drug Investigation|October 12, 2019
Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled TrialsYoung Ho Lee, Gwan Gyu SongClinical Drug Investigation|June 28, 2019
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral NeuropathyJoe Alexander, Roger A Edwards, Marina Brodsky, et al.Clinical Drug Investigation|March 11, 2022
Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized TrialSarah Sabry, Lamia Mohamed El Wakeel, Ayman Saleh, et al.Clinical Drug Investigation|September 22, 2018
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, et al.Clinical Drug Investigation|September 9, 2018
Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic ImpairmentYukio Shimasaki, Masashi Sakaki, Minoru Itou, et al.Clinical Drug Investigation|March 17, 2022
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical StudyMatteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.Clinical Drug Investigation|March 18, 2022
Multiple Sclerosis Relapses Following Cessation of FingolimodCharles B Malpas, Izanne Roos, Sifat Sharmin, et al.Clinical Drug Investigation|March 1, 2022
Atogepant for Migraine Prevention: A Systematic Review of Efficacy and SafetyAlok Singh, Mahesh Kumar BalasundaramClinical Drug Investigation|March 1, 2022
The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling StudyAnton L V Avanceña, James G Kahn, Elliot MarseillePageof 234